Scholars Central

Research articlePublished 19 Jul 2022

Efficacy and Adverse Reactions of Carboplatin, Nab-Paclitaxel Regimen Combined with Atezolizumab in the Treatment of Non-Small Cell Lung Cancer

Authors: Li Li, Zhensheng Xu, Wei Lin, Wei Lu

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Li Li”
  • BylineArticles whose byline prints “Zhensheng Xu”
  • BylineArticles whose byline prints “Wei Lin”
  • BylineArticles whose byline prints “Wei Lu”